Literature DB >> 1478838

The phenylpropionic acid load test: experience with 72 children at-risk for beta-oxidation disorders.

J F Glasgow1, R Moore, P H Robinson, P J McKiernan.   

Abstract

The urinary excretion of metabolites of orally administered phenylpropionic acid (PPA) in 72 children, aged 2 days to 16 years, thought to be at-risk of medium acyl CoA dehydrogenase deficiency has been studied. Forty had presented as Reye Syndrome, 9 as a Reye-like syndrome and 24 were sibs of decreased RS, sibs of RLS cases or sibs of infants who had died suddenly and without explanation where an autopsy revealed the presence of very heavy fatty infiltration of the liver. These studies demonstrated that PPA metabolites are maximally excreted during the 3 hours following the oral load and that this urine collection should be diagnostic. PPA loading is a relatively simple, safe test which is part of the investigation of a patient suspected of having an inborn error of metabolism.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1478838     DOI: 10.1007/bf02942363

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  14 in total

1.  Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: identification of a new inborn error of mitochondrial fatty acid beta-oxidation.

Authors:  R J Wanders; L IJlst; A H van Gennip; C Jakobs; J P de Jager; L Dorland; F J van Sprang; M Duran
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

2.  Fatty acid oxidation defects as causes of unexpected death in infancy.

Authors:  M J Bennett; F Allison; R J Pollitt; S Variend
Journal:  Prog Clin Biol Res       Date:  1990

3.  The changing epidemiology of Reye's syndrome in the United States: further evidence for a public health success.

Authors:  E S Hurwitz
Journal:  JAMA       Date:  1988-12-02       Impact factor: 56.272

4.  Inherited disorders of straight chain fatty acid oxidation.

Authors:  R J Pollitt
Journal:  Arch Dis Child       Date:  1987-01       Impact factor: 3.791

5.  The use of phenylpropionic acid as a loading test for medium-chain acyl-CoA dehydrogenase deficiency.

Authors:  J W Seakins; G Rumsby
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

6.  Screening siblings for inborn errors of fatty acid metabolism in families with a history of sudden infant death.

Authors:  M J Bennett; S Variend; R J Pollitt
Journal:  Lancet       Date:  1986 Dec 20-27       Impact factor: 79.321

7.  A simple screening test for medium-chain acyl CoA dehydrogenase deficiency.

Authors:  G Rumsby; J W Seakins; J V Leonard
Journal:  Lancet       Date:  1986-08-23       Impact factor: 79.321

8.  Reye's syndrome in the British Isles: first annual report of the joint British Paediatric Association and Communicable Disease Surveillance Centre surveillance scheme.

Authors:  S Hall; M Bellman
Journal:  Br Med J (Clin Res Ed)       Date:  1984-02-18

9.  Identification of phenylpropionylcarnitine, a new metabolite of phenylpropionic acid, in a patient with medium chain acyl-CoA dehydrogenase deficiency.

Authors:  R Moore; D S Millington; D Norwood; N Kodo; P Robinson; J F Glasgow
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

10.  Recognition of medium-chain acyl-CoA dehydrogenase deficiency in asymptomatic siblings of children dying of sudden infant death or Reye-like syndromes.

Authors:  C R Roe; D S Millington; D A Maltby; P Kinnebrew
Journal:  J Pediatr       Date:  1986-01       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.